PA
NMAX

PharVision Advisers’s Newsmax Inc NMAX Stock Holding History

PharVision Advisers’s Portfolio NMAX Stock Details NMAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,307
Closed -$95.1K – 693
2025
Q4 		$95.1K Buy
+12,307
New +$118K 0.05% 660

Other funds holding NMAX

GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's NMAX Position: Q1 2026 in Review

PharVision Advisers sold out of Newsmax Inc (NMAX) in Q1 2026, closing a stake of 12,307 shares — an estimated $95.1K sold.

PharVision Advisers first reported a position in NMAX in Q4 2025 and held it in 1 quarter. The position peaked at $95.1K in Q4 2025. 219 funds tracked by Wall St. Rank hold NMAX as of Q1 2026.

  • PharVision Advisers reported no remaining Newsmax Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,307 Newsmax Inc shares in Q1 2026, an estimated $95.1K.
  • PharVision Advisers first reported a position in Newsmax Inc in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Newsmax Inc position peaked at $95.1K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Newsmax Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.